Results

Total Results: 937 records

Showing results for "question".

  1. www.uspreventiveservicestaskforce.org/uspstf/about-uspstf/methods-and-processes/procedure-manual/procedure-manual-appendix-iv-roles-and-responsibilities-uspstf-members-serving-topic-lead
    July 01, 2017 - Assessing the evidence on each key question as convincing, adequate, or inadequate.
  2. www.uspreventiveservicestaskforce.org/home/getfilebytoken/kGvn_HBPEEdfu2rs38VN8_
    March 11, 2025 - Accuracy of Screening Instruments Key Question 2. … Citations identified through other sources (eg, reference lists, peer reviewers) KQ indicates key question … the screener being administered independently from the refer- ence standard.19 Assessment Harms Key Question … Intervention Benefits Key Question 4. … Intervention Harms Key Question 5.
  3. www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/obesity-in-children-and-adolescents-screening
    June 30, 2022 - Abbreviations: BMI=body mass index; KQ=key question … Food and Drug Administration; KQ=key question; MET=metabolic equivalent of task; USPSTF=U.S.
  4. www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/gestational-diabetes-screening
    June 06, 2019 - Abbreviations: GDM=gestational diabetes mellitus; IGT=impaired glucose tolerance; KQ=key question; T2DM … Pregnancy Outcome Study; IADPSG=International Association of Diabetes and Pregnancy Study Group; KQ=key question
  5. www.uspreventiveservicestaskforce.org/home/getfilebytoken/6desD2XJCQKF8ZDPMS-NU_
    July 01, 2005 - Results Key Question 1. … included in previous systematic evidence reviews.39-43 Key Question 2a. … Key Question 2b. … Key Question 2c. … Key Question 5.
  6. www.uspreventiveservicestaskforce.org/uspstf/document/evidence-summary/obesity-in-children-and-adolescents-screening-june-2017
    June 20, 2017 - Effects of Interventions on Health Outcomes Key Question 3. … Efficacy of Interventions by Patient Subgroups Key Question 4c. … Harms of Interventions Key Question 5. … The following number of articles were included for Key Question 1 (n=0), Key Question 2 (n=0), Key Question … 3 (n=26), Key Question 4 (n=98), and Key Question 5 (n=33).
  7. www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/latent-tuberculosis-infection-screening
    May 02, 2023 - Benefits of Screening Key Question 1. … Screening Accuracy Key Question 2a. … Harms of Screening Key Question 4a. … Key Question 4b. Do these harms differ by screening method or strategy? Key Question 4c. … Harms of Treatment Key Question 5.
  8. JAMA JATS (pdf file)

    www.uspreventiveservicestaskforce.org/home/getfilebytoken/dvDjnZzW9PDxzKBauB4QxA
    August 21, 2018 - Results Effectiveness of Screening Key Question 1. … Key Question 1a. … Key Question 1b. … Harms of hrHPV Screening Key Question 2. … Key Question 2a.
  9. www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/falls-prevention-community-dwelling-older-adults-interventions
    July 21, 2022 - Contextual Question Contextual
  10. www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/syphilis-infection-nonpregnant-adults-adolescents-screening
    January 28, 2021 - Abbreviations : AUC = area under the curve; c = concordance; HIV = human immunodeficiency virus; KQ = key question
  11. www.uspreventiveservicestaskforce.org/home/getfilebytoken/bF5BNLvASN5r9EnP3VTJPN
    December 01, 2010 - 1), intermediate cardiovascular disease–related outcomes (key question 2), behavioral outcomes (key … question 3), and harms of the counseling interventions (key question 4). … Data Sources and Searches To identify literature published for each key question since the previous … Key Question 4: Harms Adverse effects were rarely noted in physical activity counseling trials. … CVD � cardiovascular disease; KQ � key question.
  12. www.uspreventiveservicestaskforce.org/home/getfilebytoken/sZN5HHS8w5Sar6bBPabsaB
    June 01, 2008 - RESULTS Key Question 1 Is there direct evidence that systematic screening for type 2 diabetes, impaired … Key Question 2 Does beginning treatment of type 2 diabetes early as a result of screening provide an … We identified no studies that directly explored this question by comparing treatment effects between … Key question 2: diabetes treatment 8 studies RCTs with diabetes vs. … Key question 5: adverse effects of treatment 24 studies Systematic reviews (111–113, 115–124, 126–136
  13. www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/carotid-artery-stenosis-screening
    November 14, 2019 - stenting; CAS: carotid artery stenosis; CEA: carotid endarterectomy; CVD: cardiovascular disease; KQ: key question
  14. www.uspreventiveservicestaskforce.org/home/getfilebytoken/myqvgr-dsW7k3eQbwj4aR4
    February 01, 2013 - Articles excluded for key question 1 (n = 105) Relevance: 1 Location/setting: 26 Inadequate control … 1 (n = 0) Articles excluded for key question 2 (n = 82) Relevance: 1 Location/setting: 26 Inadequate … 2 (n = 23 [18 trials]) Articles excluded for key question 3 (n = 87) Relevance: 8 Location/setting … 3 (n = 24 [19 trials]) Articles reviewed for key question 1 (n = 105) Articles reviewed for key question … 2 (n = 105) Articles reviewed for key question 3 (n = 111) Records identified through database searching
  15. www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary25/folic-acid-to-prevent-neural-tube-defects-preventive-medication-2009
    May 15, 2009 - We organized synthesized evidence by key question. … Key Question 1 Does folic acid supplementation in women of childbearing age reduce the risk for a pregnancy … Our literature search to answer this question returned 4 articles that met the inclusion criteria, were … Key Question 2 Does folic acid supplementation in women of childbearing age increase the risk for any … Note: KQ = key question. Text Description .
  16. www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan/human-immunodeficiency-virus-hiv-infection-pregnant-nonpregnant-adults
    February 22, 2024 - EFV = efavirenz; EVG = elvitegravir; EVG/c = elvitegravir/cobicistat; FTC = emtricitabine; KQ = Key Question … ritonavir; DTG = dolutegravir; FTC = emtricitabine; INSTI = integrase strand transfer inhibitor; KQ = Key Question
  17. www.uspreventiveservicestaskforce.org/home/getfilebytoken/y6xRBv7uSZY5bGCx7y48x7
    May 01, 2009 - We organized synthesized evidence by key question. … Key Question 1 Does folic acid supplementation in women of childbear- ing age reduce the risk for a … Our literature search to answer this question returned 4 articles that met the inclusion criteria, were … Key Question 2 Does folic acid supplementation in women of childbear- ing age increase the risk for … Studies Excluded After Abstraction and Quality Rating for Key Question 2 (Harms) Study, Year (Reference
  18. www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary/hypertension-in-adults-screening
    April 27, 2021 - Benefits of Screening Key Question 1. … Test Accuracy Key Question 2. … Key Question 2a. What screening protocol characteristics define the best test accuracy? … Key Question 3. … Key Question 3a. What confirmation protocol characteristics define the best test accuracy?
  19. www.uspreventiveservicestaskforce.org/uspstf/document/draft-research-plan/breast-cancer-medication-use-reduce-risk
    December 28, 2023 - according to design-specific criteria Abbreviations: DCIS=ductal carcinoma in situ; KQ=key question
  20. www.uspreventiveservicestaskforce.org/home/getfilebytoken/svy-CsBNaoaeb7wRGFvLdW
    January 26, 2016 - Benefits of Screening Key Question 1. … Key Question 1a. … Harms of Screening Key Question 3. … Harms of Treatment Key Question 5. … Key Question 5b.

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: